T-cell/histiocyte-rich large B-cell lymphoma: A clinicopathologic distinct subtype of diffuse large B-cell lymphoma Report uri icon

Overview

MeSH Major

  • DNA-Binding Proteins
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse
  • Mutation, Missense
  • Nuclear Proteins
  • Transcription Factors

abstract

  • T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a morphologic subtype of diffuse large B-cell lymphoma and is characterized by the predominance of nonneoplastic T cells and histiocytes admixed with a small number of large neoplastic B cells. It is a biologically distinct disease characterized by male preponderance, advanced-stage disease at initial presentation, and high incidence of extranodal dissemination. T-cell/histiocyte-rich large B-cell lymphoma can potentially be misdiagnosed owing to its morphologic and/or immunophenotypic resemblance to other lymphomas, particularly nodular lymphocyte predominant Hodgkin lymphoma. Immunohistochemical evaluation for both the neoplastic and reactive components is essential for a correct diagnosis of this entity. We present 2 THRLBCL cases from our pathology archives and discuss the morphologic, immunophenotypic, molecular and biologic features of THRLBCL, with particular attention to its differential diagnoses. © 2012 Lippincott Williams & Wilkins, Inc.

publication date

  • March 2012

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1097/PCR.0b013e318253218e

Additional Document Info

start page

  • 52

end page

  • 56

volume

  • 17

number

  • 2